Novo Nordisk's $4.1 Billion Bet: How BE&K Just Won the Biggest Pharma Build in the Southeast

from The Deep Dive: Where Elite Builders Share the Secrets Behind Their Success

Novo Nordisk is investing $4.1 billion in a 1.4-million-square-foot, 10-building manufacturing expansion in Clayton, North Carolina to ramp Ozempic and Wegovy production — and BE&K Building Group just landed the build as Design-Builder and Agency Construction Manager across a 56-acre campus. We break down why life-sciences construction is the new megaproject gold rush, how the design-build delivery model changes who wins subcontracts, and how mid-market contractors can position for phased 2027-2

Episode metadata supplied by the publisher feed · Published Jul 4, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Novo Nordisk's $4.1 Billion Bet: How BE&K Just Won the Biggest Pharma Build in the Southeast

0:00 19:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Deep Dive: Where Elite Builders Share the Secrets Behind Their Success?

This episode is 19 minutes long.

When was this The Deep Dive: Where Elite Builders Share the Secrets Behind Their Success episode published?

This episode was published on July 4, 2026.

Can I download this The Deep Dive: Where Elite Builders Share the Secrets Behind Their Success episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!